Literature DB >> 24892966

Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem.

Ilyssa O Gordon1, Neha Agrawal, John R Goldblum, Claudio Fiocchi, Florian Rieder.   

Abstract

Chronic intestinal inflammation and impaired tissue repair leading to intestinal fibrosis are a commonly observed complication in inflammatory bowel disease. This is particularly true for small bowel Crohn's disease. However, the development of fibrosis in ulcerative colitis has remained largely unexplored. This is surprising, given knowledge about its prevalence for decades, well described histopathologic features of fibrotic and stricturing ulcerative colitis, the relevance of the extracellular matrix for intestinal inflammation and fibrosis, and the clinical impact of fibrosis on stricture formation, motility, and the necessary discrimination from colonic malignancy. This systematic review summarizes the current knowledge of ulcerative colitis-related fibrosis, including epidemiology, basic mechanisms, histopathology, and clinical implications.

Entities:  

Mesh:

Year:  2014        PMID: 24892966     DOI: 10.1097/MIB.0000000000000080

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  30 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

Review 2.  Intestinal fibrosis: ready to be reversed.

Authors:  Giovanni Latella; Florian Rieder
Journal:  Curr Opin Gastroenterol       Date:  2017-07       Impact factor: 3.287

Review 3.  New endoscopic approach of anti-fibrotic therapy for inflammatory bowel disease.

Authors:  Kenji Suzuki; Hiroyuki Yoneyama
Journal:  Ann Transl Med       Date:  2017-04

Review 4.  Role of Rho kinase signal pathway in inflammatory bowel disease.

Authors:  Yuan Huang; Shiyu Xiao; Quanhang Jiang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Managing Intestinal Fibrosis in Patients With Inflammatory Bowel Disease.

Authors:  Florian Rieder
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-02

6.  A Step Forward in the Understanding of Structural and Functional Bowel Damage in Patients with Ulcerative Colitis.

Authors:  Catarina Gouveia; Joana Torres
Journal:  GE Port J Gastroenterol       Date:  2017-11-08

7.  Toward an antifibrotic therapy for inflammatory bowel disease.

Authors:  Florian Rieder
Journal:  United European Gastroenterol J       Date:  2016-07-14       Impact factor: 4.623

Review 8.  Novel biomarkers of fibrosis in Crohn's disease.

Authors:  Gianluca Pellino; Pierlorenzo Pallante; Francesco Selvaggi
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

9.  PET/MR Versus PET/CT Imaging: Impact on the Clinical Management of Small-Bowel Crohn's Disease.

Authors:  Gianluca Pellino; Emanuele Nicolai; Onofrio A Catalano; Severo Campione; Francesco P D'Armiento; Marco Salvatore; Alberto Cuocolo; Francesco Selvaggi
Journal:  J Crohns Colitis       Date:  2015-11-15       Impact factor: 9.071

10.  Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.

Authors:  I O Gordon; N Agrawal; E Willis; J R Goldblum; R Lopez; D Allende; X Liu; D Y Patil; L Yerian; F El-Khider; C Fiocchi; F Rieder
Journal:  Aliment Pharmacol Ther       Date:  2018-02-06       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.